{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T04:04:46Z","timestamp":1750737886356,"version":"3.41.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T00:00:00Z","timestamp":1748476800000},"content-version":"vor","delay-in-days":58,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.rgmxen.2024.12.002","type":"journal-article","created":{"date-parts":[[2025,6,9]],"date-time":"2025-06-09T19:29:00Z","timestamp":1749497340000},"page":"323-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Should mycophenolate mofetil be first-line treatment in autoimmune hepatitis?"],"prefix":"10.1016","volume":"90","author":[{"given":"J.A.","family":"Torres-D\u00edaz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.","family":"Garc\u00eda-Ju\u00e1rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rgmxen.2024.12.002_bib0005","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the american association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0010","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.cgh.2019.11.013","article-title":"Rapid response to treatment of autoimmune hepatitis associated with remission at 6 and 12 months","volume":"18","author":"Pape","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jhep.2024.03.021","article-title":"Treatment response and clinical event-free survival in autoimmune hepatitis: a Canadian multicentre cohort study","volume":"81","author":"Plagiannakos","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0020","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/apt.15248","article-title":"Beneficial response to mycophenolate mofetil by patients with autoimmune hepatitis who have failed standard therapy, is predicted by older age and lower immunoglobulin G and INR levels","volume":"49","author":"Nicoll","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0025","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jhep.2010.12.032","article-title":"Mycophenolate for the treatment of autoimmune hepatitis: prospective assessment of its efficacy and safety for induction and maintenance of remission in a large cohort of treatment- na\u00efve patients","volume":"55","author":"Zachou","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0030","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.jhep.2023.11.032","article-title":"An open-label randomised-controlled trial of azathioprine vs mycophenolate mofetil for the induction of remission in treatment-naive autoimmune hepatitis","volume":"80","author":"Snijders","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100601","article-title":"Long-term results of mycophenolate mofetil vs azathioprine use in individuals with autoimmune hepatitis","author":"Dalekos","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0040","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejmg.2016.09.014","article-title":"Mycophenolate mofetil embryopathy: a newly recognized teratogenic syndrome","volume":"60","author":"Perez-Aytes","year":"2017","journal-title":"Eur J Med Genet"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0045","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/apt.13584","article-title":"A real-world study focused on the long-term efficacy of mycophenolate mofetil as first-line treatment of autoimmune hepatitis","volume":"43","author":"Zachou","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.rgmxen.2024.12.002_bib0050","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.798602","article-title":"First results from a propensity matching trial of mycophenolate mofetil vs. azathioprine in treatment-naive AIH patients","volume":"12","author":"Dalekos","year":"2022","journal-title":"Front Immunol"}],"container-title":["Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25000593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2255534X25000593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T15:23:59Z","timestamp":1750692239000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2255534X25000593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2255534X25000593"],"URL":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.12.002","relation":{},"ISSN":["2255-534X"],"issn-type":[{"type":"print","value":"2255-534X"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Should mycophenolate mofetil be first-line treatment in autoimmune hepatitis?","name":"articletitle","label":"Article Title"},{"value":"Revista de Gastroenterolog\u00eda de M\u00e9xico (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmxen.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.rgmx.2024.12.005","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Asociaci\u00f3n Mexicana de Gastroenterolog\u00eda. Published by Masson Doyma M\u00e9xico S.A.","name":"copyright","label":"Copyright"}]}}